-
-
-
-
-
-
-
Sagimet Biosciences Inc (SGMT) PT Raised to $28 at Oppenheimer
-
-
-
-
-
-
-
Sagimet Biosciences (SGMT) PT Raised to $35 at Citizens After MASH Drug Presentations
-
-
-
-
-
-
-
Sagimet Biosciences (SGMT) Announces Positive Phase 3 Results for Denifanstat for the Treatment of Moderate-to-Severe Acne from Partner Ascletis
-
-
-
-
-
-
-
Leerink Partners Reiterates Outperform Rating on Sagimet Biosciences Inc (SGMT)
-
-
-
-
460,601 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All

